Liabilities and Equity in USD of IDEXX LABORATORIES INC /DE from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
IDEXX LABORATORIES INC /DE quarterly Liabilities and Equity history and change rate from Q2 2010 to Q3 2025.
  • IDEXX LABORATORIES INC /DE Liabilities and Equity for the quarter ending 30 Sep 2025 was $3,386,712,000, a 1.1% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,386,712,000 +$35,946,000 +1.1% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $3,330,794,000 -$84,073,000 -2.5% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $3,213,689,000 -$139,826,000 -4.2% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $3,293,443,000 +$33,518,000 +1% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $3,350,766,000 +$264,362,000 +8.6% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $3,414,867,000 +$544,061,000 +19% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $3,353,515,000 +$545,117,000 +19% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $3,259,925,000 +$513,160,000 +19% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $3,086,404,000 +$446,337,000 +17% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $2,870,806,000 +$263,621,000 +10% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $2,808,398,000 +$215,709,000 +8.3% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $2,746,765,000 +$309,562,000 +13% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $2,640,067,000 +$254,323,000 +11% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $2,607,185,000 +$195,036,000 +8.1% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $2,592,689,000 +$265,304,000 +11% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $2,437,203,000 +$142,642,000 +6.2% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $2,385,744,000 +$338,337,000 +17% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $2,412,149,000 +$451,436,000 +23% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $2,327,385,000 +$441,140,000 +23% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $2,294,561,000 +$462,086,000 +25% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $2,047,407,000 +$295,926,000 +17% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $1,960,713,000 +$236,476,000 +14% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $1,886,245,000 +$205,277,000 +12% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $1,832,475,000 +$295,126,000 +19% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $1,751,481,000 +$206,951,000 +13% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $1,724,237,000 +$203,552,000 +13% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $1,680,968,000 +$211,476,000 +14% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $1,537,349,000 -$176,067,000 -10% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $1,544,530,000 -$124,804,000 -7.5% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $1,520,685,000 -$116,452,000 -7.1% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 $1,469,492,000 -$102,599,000 -6.5% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 $1,713,416,000 +$182,712,000 +12% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 $1,669,334,000 +$168,964,000 +11% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $1,637,137,000 +$147,896,000 +9.9% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 $1,572,091,000 +$93,444,000 +6.3% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $1,530,704,000 +$55,711,000 +3.8% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q3 2016 $1,500,370,000 +$23,160,000 +1.6% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 $1,489,241,000 +$11,871,000 +0.8% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 $1,478,647,000 +$47,633,000 +3.3% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 $1,474,993,000 +$90,782,000 +6.6% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $1,477,210,000 +$186,578,000 +14% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $1,477,370,000 +$194,177,000 +15% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $1,431,014,000 +$168,690,000 +13% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $1,384,211,000 +$153,695,000 +12% 31 Dec 2014 10-K 17 Feb 2016 2015 FY
Q3 2014 $1,290,632,000 +$95,394,000 +8% 30 Sep 2014 10-Q 24 Oct 2014 2014 Q3
Q2 2014 $1,283,193,000 +$119,122,000 +10% 30 Jun 2014 10-Q 25 Jul 2014 2014 Q2
Q1 2014 $1,262,324,000 +$129,686,000 +11% 31 Mar 2014 10-Q 25 Apr 2014 2014 Q1
Q4 2013 $1,230,516,000 +$126,914,000 +12% 31 Dec 2013 10-K 17 Feb 2015 2014 FY
Q3 2013 $1,195,238,000 +$101,887,000 +9.3% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 $1,164,071,000 +$96,754,000 +9.1% 30 Jun 2013 10-Q 23 Jul 2013 2013 Q2
Q1 2013 $1,132,638,000 +$71,533,000 +6.7% 31 Mar 2013 10-Q 23 Apr 2013 2013 Q1
Q4 2012 $1,103,602,000 +$72,788,000 +7.1% 31 Dec 2012 10-K 18 Feb 2014 2013 FY
Q3 2012 $1,093,351,000 +$124,152,000 +13% 30 Sep 2012 10-Q 19 Oct 2012 2012 Q3
Q2 2012 $1,067,317,000 +$116,742,000 +12% 30 Jun 2012 10-Q 20 Jul 2012 2012 Q2
Q1 2012 $1,061,105,000 +$151,627,000 +17% 31 Mar 2012 10-Q 20 Apr 2012 2012 Q1
Q4 2011 $1,030,814,000 +$133,670,000 +15% 31 Dec 2011 10-K 19 Feb 2013 2012 FY
Q3 2011 $969,199,000 +$106,902,000 +12% 30 Sep 2011 10-Q 21 Oct 2011 2011 Q3
Q2 2011 $950,575,000 +$116,840,000 +14% 30 Jun 2011 10-Q 22 Jul 2011 2011 Q2
Q1 2011 $909,478,000 31 Mar 2011 10-Q 21 Apr 2011 2011 Q1
Q4 2010 $897,144,000 31 Dec 2010 10-K 17 Feb 2012 2011 FY
Q3 2010 $862,297,000 30 Sep 2010 10-Q 22 Oct 2010 2010 Q3
Q2 2010 $833,735,000 30 Jun 2010 10-Q 23 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.